Treatment of Trichomoniasis
Metronidazole 500 mg orally twice daily for 7 days is the preferred treatment for trichomoniasis, as it achieves superior cure rates (89%) compared to single-dose therapy (81%) in women. 1
First-Line Treatment Regimen
Recommended regimen: Metronidazole 500 mg orally twice daily for 7 days 2, 3, 4
- This multi-day regimen demonstrates significantly better efficacy than single-dose treatment in the most recent high-quality randomized controlled trial 1
- Cure rates of 90-95% are achieved with this regimen 2, 3
- The 2018 trial showed 11% treatment failure with 7-day dosing versus 19% failure with single-dose therapy (p<0.0001) 1
Alternative regimen: Metronidazole 2 g orally as a single dose 2, 3, 5
- This remains an acceptable option when medication adherence is a significant concern 3
- Historically recommended as first-line, but recent evidence suggests inferior efficacy 1
- FDA-approved for trichomoniasis treatment 5
Second-line option: Tinidazole 2 g orally as a single dose 6
- Equally effective as single-dose metronidazole with 95-97.5% cure rates 7
- FDA-approved specifically for trichomoniasis 6
- Consider when metronidazole intolerance (not allergy) is present 6
Critical Management Principles
Partner treatment is mandatory:
- All sexual partners must be treated simultaneously to prevent reinfection 2, 3, 4
- Patients must abstain from sexual activity until both partners complete treatment and are asymptomatic 2, 3, 4
- Failure to treat partners is the most common cause of recurrent infection 4
Alcohol avoidance:
- Patients must avoid alcohol during treatment and for at least 24 hours after completing metronidazole 3
- Metronidazole causes a disulfiram-like reaction with alcohol (nausea, vomiting, flushing, headache, abdominal cramps) 3
Treatment Failure Algorithm
First treatment failure:
- Re-treat with metronidazole 500 mg twice daily for 7 days 2, 3, 4
- Ensure partner was treated and reinfection is excluded 2
Second treatment failure:
- Administer metronidazole 2 g once daily for 3-5 days 2, 3, 4
- Most strains with diminished susceptibility respond to higher doses 2
Persistent failure after appropriate therapy:
- Consult infectious disease specialist 3, 4
- Obtain susceptibility testing of T. vaginalis to metronidazole 2, 4
- CDC consultation is available for refractory cases 2
Special Populations
Pregnancy:
- First trimester: Metronidazole is contraindicated 2
- Second and third trimesters: Metronidazole 2 g orally as a single dose 2, 4
- Treatment is important as trichomoniasis is associated with premature rupture of membranes and preterm delivery 2, 4
HIV infection:
Metronidazole allergy:
- Effective alternatives are extremely limited 2, 4
- Desensitization may be required for true immediate-type allergy 3, 4
- Tinidazole is not appropriate as it may cross-react despite being a different nitroimidazole 8
Follow-Up Recommendations
- Routine follow-up is unnecessary for patients who become asymptomatic after treatment 2, 3, 4
- Re-evaluate only if symptoms persist, considering reinfection or resistant infection 3, 4
Common Pitfalls to Avoid
Do NOT use topical metronidazole gel:
- Topical preparations have efficacy <50% for trichomoniasis 3, 8, 4
- They fail to achieve therapeutic levels in the urethra and perivaginal glands 2
- This is only approved for bacterial vaginosis, not trichomoniasis 2, 5
Do NOT treat without partner notification: